Toripalimab Combined With Capecitabine as Postoperative Adjuvant Therapy for Patients With Resectable Advanced Extrahepatic Biliary Tract Cancer
Clinical trial NCT06717464 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT06717464
- Sponsor
- Tianjin Medical University Cancer Institute and Hospital
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2024-11-12
- Primary completion
- 2026-12-31
- Enrollment
- 110
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.